Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Gorilla and King Portfolio Candidates -- Ignore unavailable to you. Want to Upgrade?

To: Percival 917 who wrote (3462)	7/5/1999 8:07:00 PM
From: megazoo	Read Replies (1) \| Respond to of 54805

<so their monopoly may not last> Nobody said the monopoly would last. The FTC LOST the case and is appealing. The day the FTC lost, VISX went up 17 points, 6 weeks ago. The day FTC filed an appeal, VISX went up 6 points. Tell me something, why would doctors not opt for other machines, such as Nidek, Summit - they don't have to pay for any royalty. Why do they complain and continue to shell out 250 bucks to VISX? Because, there is a factor of 'trust' in the business, and VISX has won that trust. Not to mention, their technology is much superior to others. Consumers DEMAND VISX. I will, when I use a fraction of my VISX gains to choose a VISX-based eye surgery this fall. Best.